Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003574 · ClinicalTrials.gov registry record · Phase 2
Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors
A Phase 2 study, sponsored by New Approaches to Brain Tumor Therapy Consortium.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00003574 is a Phase 2 study that has completed, run by New Approaches to Brain Tumor Therapy Consortium.
The verdict
NCT00003574, a Phase 2 study, has completed, sponsored by New Approaches to Brain Tumor Therapy Consortium.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients who are undergoing surgical removal of progressive or recurrent malignant brain tumors.
Interventions
- RADIATION brachytherapy
- PROCEDURE surgical procedure
- RADIATION iodine I 125
- RADIATION intraoperative radiation therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-04 |
| Est. Completion | 2004-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003574
The ClinicalTrials.gov registry entry for NCT00003574 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is New Approaches to Brain Tumor Therapy Consortium, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which brachytherapy is the first listed.
NCT00003574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003574 about?
NCT00003574 is a clinical study titled "Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy in treating patients who are undergoing surgical removal of progressive or recurr...
What is the current status of trial NCT00003574?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-04. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00003574?
The interventions under investigation include: brachytherapy (RADIATION), surgical procedure (PROCEDURE), iodine I 125 (RADIATION), intraoperative radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00003574?
This trial is sponsored by New Approaches to Brain Tumor Therapy Consortium, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.